Literature DB >> 21621351

Low gestational age and chronic lung disease are synergistic risk factors for retinopathy of prematurity.

Vasileios Giapros1, Aikaterini Drougia, Ioannis Asproudis, Paraskevi Theocharis, Styliani Andronikou.   

Abstract

AIMS: This retrospective, population based study was designed to investigate risk factors for development of retinopathy of prematurity (ROP) and their possible interrelationships, in neonates of gestational age (GA) <32 weeks born in a well-defined geographical region. STUDY DESIGN-
SUBJECTS: The study population included all preterm infants born alive with GA 24-32 weeks in Northwestern Greece during a 9-year period and hospitalised in the regional neonatal intensive care unit (NICU). OUTCOME MEASUREMENTS: The association was assessed of the presence of ROP with maternal factors: age, pathology of pregnancy, in-vitro fertilisation, multiple gestation, mode of delivery, perinatal factors: gender, antenatal steroids, transportation, resuscitation, GA, birth weight (BW), small for GA status and postnatal morbidity: chronic lung disease (CLD), intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), respiratory distress syndrome (RDS), maximum O(2) needs, hypoxic/hyperoxic episodes, patent ductus arteriosus (PDA), sepsis, using multiple logistic regression analysis.
RESULTS: Of 189 infants without congenital anomalies born at GA 24-32 weeks ROP was diagnosed in 24 (12.7%) (>grade 2: 6). Logistic regression analysis showed ROP to be strongly associated with GA, odds ratio (OR) 2.1, confidence interval (CI) 1.3-3.3, p<0.01 and CLD, OR 10.2, CI 2.3-44, p<0.01, respectively, independent of confounding factors. By estimating interaction on an additive scale it was shown that the combined risk effect of GA and CLD was larger than the sum of the individual risk effects, implying synergistic effect.
CONCLUSIONS: ROP was closely and independently related to both low GA and the diagnosis of CLD, which were interrelated in the development of ROP.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21621351     DOI: 10.1016/j.earlhumdev.2011.05.003

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  7 in total

1.  Retinopathy of prematurity occurrence and evaluation of screening policy in a large tertiary Greek cohort.

Authors:  Asimina Mataftsi; Stella Moutzouri; Paraskevi Karagianni; Nikolaos Ziakas; Vasiliki Soubasi; Periklis Brazitikos; Anna-Bettina Haidich
Journal:  Int Ophthalmol       Date:  2019-10-22       Impact factor: 2.031

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

3.  Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence.

Authors:  Kaveh Fadakar; Mohammadreza Mehrabi Bahar; Hamid Riazi-Esfahani; Afsaneh Azarkish; Afsar Dastjani Farahani; Mostafa Heidari; Fatemeh Bazvand
Journal:  Int Ophthalmol       Date:  2022-01-20       Impact factor: 2.029

4.  Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis.

Authors:  Eduardo Villamor-Martinez; Giacomo Cavallaro; Genny Raffaeli; Owais M M Mohammed Rahim; Silvia Gulden; Amro M T Ghazi; Fabio Mosca; Pieter Degraeuwe; Eduardo Villamor
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

5.  Cumulative evidence for association of sepsis and retinopathy of prematurity.

Authors:  Jichong Huang; Ying Tang; Tingting Zhu; Yafei Li; Hua Chun; Yi Qu; Dezhi Mu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

6.  Early Postnatal Oxygen Exposure Predicts Choroidal Thinning in Neonates.

Authors:  Ye He; Moritz Pettenkofer; Muneeswar Gupta Nittala; Srinivas R Sadda; Irena Tsui; Alison Chu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

7.  Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome.

Authors:  Bita Najafian; Seyed Hasan Fakhraie; Seyed Abulfazl Afjeh; Mohammad Kazemian; Majid Shohrati; Amin Saburi
Journal:  Iran Red Crescent Med J       Date:  2014-04-05       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.